Skip to main content
. 2017 Feb 16;8(12):20113–20121. doi: 10.18632/oncotarget.15390

Figure 3. Effect of cabozantinib treatment on primary osteoblast.

Figure 3

A. Representative images of Alp and Alizarin Red assay in untreated or treated osteoblasts (DMSO). B. Alp staining and C. Alizarin Red fluorescence quantification in untreated or treated osteoblasts (DMSO).